CO6480993A2 - Diagnostico de una parasitosis tal como la leishmaniasis usando un extracto de proteinas ribosomicas (rpe) - Google Patents
Diagnostico de una parasitosis tal como la leishmaniasis usando un extracto de proteinas ribosomicas (rpe)Info
- Publication number
- CO6480993A2 CO6480993A2 CO12000715A CO12000715A CO6480993A2 CO 6480993 A2 CO6480993 A2 CO 6480993A2 CO 12000715 A CO12000715 A CO 12000715A CO 12000715 A CO12000715 A CO 12000715A CO 6480993 A2 CO6480993 A2 CO 6480993A2
- Authority
- CO
- Colombia
- Prior art keywords
- parasitosis
- rpe
- leishmaniasis
- ribosomic
- diagnosis
- Prior art date
Links
- 208000030852 Parasitic disease Diseases 0.000 title abstract 4
- 208000004554 Leishmaniasis Diseases 0.000 title abstract 3
- 238000003745 diagnosis Methods 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 238000000034 method Methods 0.000 abstract 3
- 238000002405 diagnostic procedure Methods 0.000 abstract 2
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56905—Protozoa
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
- Secondary Cells (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Objeto de la Invención: Método de diagnostico mejorado para un parasitosis tal como Leishmaniasis, que no tenga todas las desventajas de los métodos existentes. Características de la Invención: Método para diagnosticar una parasitosis en un sujeto usando RPE, en donde el método comprende determinar en un muestra que se obtuvo del sujeto si está presente un anticuerpo que reconoce al RPE. Campo de Aplicación: Método de diagnostico para una parasitosis tal como Leishmaniasis usando un RPE.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09165282 | 2009-07-13 | ||
US26721409P | 2009-12-07 | 2009-12-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO6480993A2 true CO6480993A2 (es) | 2012-07-16 |
Family
ID=41211952
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO12000715A CO6480993A2 (es) | 2009-07-13 | 2012-01-03 | Diagnostico de una parasitosis tal como la leishmaniasis usando un extracto de proteinas ribosomicas (rpe) |
Country Status (20)
Country | Link |
---|---|
US (1) | US8969019B2 (es) |
EP (1) | EP2454593A1 (es) |
JP (1) | JP5805635B2 (es) |
KR (1) | KR20120061082A (es) |
CN (1) | CN102483413A (es) |
AP (1) | AP3516A (es) |
AU (1) | AU2010272566B2 (es) |
BR (1) | BR112012000679A2 (es) |
CA (1) | CA2767865A1 (es) |
CO (1) | CO6480993A2 (es) |
EC (1) | ECSP12011662A (es) |
IL (1) | IL217528A (es) |
IN (1) | IN2012DN00401A (es) |
MA (1) | MA33514B1 (es) |
MX (1) | MX2012000675A (es) |
PE (1) | PE20120818A1 (es) |
RU (1) | RU2558233C2 (es) |
TN (1) | TN2012000014A1 (es) |
WO (1) | WO2011006891A1 (es) |
ZA (1) | ZA201200295B (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SA110310855B1 (ar) * | 2009-11-13 | 2014-09-16 | Laboratories Leti S L Unipersonal | استخدام مصدر l3 و/ أو l5 كلقاح أو كوسيلة تشخيصية لمرض طفيلي |
JP2016053535A (ja) * | 2014-09-04 | 2016-04-14 | 国立大学法人 東京大学 | 皮膚型リーシュマニア症の検査用試薬又はキット、及び皮膚型リーシュマニア症の検査方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5359681A (en) | 1993-01-11 | 1994-10-25 | University Of Washington | Fiber optic sensor and methods and apparatus relating thereto |
US5912166A (en) * | 1995-04-21 | 1999-06-15 | Corixa Corporation | Compounds and methods for diagnosis of leishmaniasis |
US6500437B1 (en) * | 1995-09-22 | 2002-12-31 | Corixa Corporation | Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
US6613337B1 (en) * | 1997-02-12 | 2003-09-02 | Corixa Corporation | Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
EP1624063B1 (en) * | 1998-12-23 | 2009-04-22 | Laboratorios LETI, S.L. | Chimeric gene encoding the antigenic determinants of four proteins of L. infantum |
PT1624063E (pt) * | 1998-12-23 | 2009-06-19 | Leti Sl Lab | Gene quimérico que codifica os determinantes antigénicos das quatro proteínas de l. infantum |
ES2169995B1 (es) | 2000-04-17 | 2003-12-01 | Leti Lab | Composicion a base de la proteina lip2a y su uso en la preparacion de un medicamento para suscitar una respuesta inmune contra un antigeno. |
JP2006518184A (ja) * | 2002-09-20 | 2006-08-10 | アクゾ・ノベル・エヌ・ベー | 弱毒寄生虫生ワクチン |
RU2380710C2 (ru) | 2003-11-05 | 2010-01-27 | К.Б.Ф. Лети, С.Л. Юниперсонал | Лечение, диагностика или профилактика лейшманиоза, вызванного различными видами паразитов, кроме вида, из которого получены гистоны, с использованием всех четырех гистонов h2a, h2b, h3 и h4, выделенных из leishmania infantum с использованием вектора, содержащего нуклеотиды, кодирующие указанные гистоны |
-
2010
- 2010-07-13 US US13/383,482 patent/US8969019B2/en not_active Expired - Fee Related
- 2010-07-13 RU RU2012104855/10A patent/RU2558233C2/ru not_active IP Right Cessation
- 2010-07-13 EP EP10730190A patent/EP2454593A1/en not_active Withdrawn
- 2010-07-13 AU AU2010272566A patent/AU2010272566B2/en not_active Ceased
- 2010-07-13 IN IN401DEN2012 patent/IN2012DN00401A/en unknown
- 2010-07-13 MX MX2012000675A patent/MX2012000675A/es active IP Right Grant
- 2010-07-13 KR KR1020127002828A patent/KR20120061082A/ko not_active Application Discontinuation
- 2010-07-13 JP JP2012520004A patent/JP5805635B2/ja not_active Expired - Fee Related
- 2010-07-13 WO PCT/EP2010/060058 patent/WO2011006891A1/en active Application Filing
- 2010-07-13 CN CN2010800315957A patent/CN102483413A/zh active Pending
- 2010-07-13 CA CA2767865A patent/CA2767865A1/en not_active Abandoned
- 2010-07-13 AP AP2012006118A patent/AP3516A/xx active
- 2010-07-13 PE PE2012000040A patent/PE20120818A1/es not_active Application Discontinuation
- 2010-07-13 BR BR112012000679A patent/BR112012000679A2/pt not_active IP Right Cessation
-
2012
- 2012-01-03 CO CO12000715A patent/CO6480993A2/es unknown
- 2012-01-10 TN TNP2012000014A patent/TN2012000014A1/en unknown
- 2012-01-12 IL IL217528A patent/IL217528A/en not_active IP Right Cessation
- 2012-01-13 ZA ZA2012/00295A patent/ZA201200295B/en unknown
- 2012-02-08 MA MA34612A patent/MA33514B1/fr unknown
- 2012-02-10 EC ECSP12011662 patent/ECSP12011662A/es unknown
Also Published As
Publication number | Publication date |
---|---|
IL217528A0 (en) | 2012-02-29 |
ECSP12011662A (es) | 2012-06-29 |
AU2010272566A1 (en) | 2012-02-02 |
JP2012533074A (ja) | 2012-12-20 |
TN2012000014A1 (en) | 2013-09-19 |
WO2011006891A1 (en) | 2011-01-20 |
BR112012000679A2 (pt) | 2016-11-01 |
ZA201200295B (en) | 2012-09-26 |
IL217528A (en) | 2016-05-31 |
US8969019B2 (en) | 2015-03-03 |
KR20120061082A (ko) | 2012-06-12 |
EP2454593A1 (en) | 2012-05-23 |
RU2558233C2 (ru) | 2015-07-27 |
RU2012104855A (ru) | 2013-08-20 |
MX2012000675A (es) | 2012-06-08 |
AP2012006118A0 (en) | 2012-02-29 |
MA33514B1 (fr) | 2012-08-01 |
IN2012DN00401A (es) | 2015-08-21 |
US20120178109A1 (en) | 2012-07-12 |
AU2010272566B2 (en) | 2015-03-26 |
CA2767865A1 (en) | 2011-01-20 |
CN102483413A (zh) | 2012-05-30 |
JP5805635B2 (ja) | 2015-11-04 |
PE20120818A1 (es) | 2012-07-12 |
AP3516A (en) | 2016-01-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112014013082A2 (pt) | método para detectar adutos nucleossomos | |
EA201590027A1 (ru) | Способы детекции заболеваний или состояний | |
EA201600085A1 (ru) | Набор для обнаружения соевого события syht0h2 | |
UY32501A (es) | Anticuerpo antagonista específico para el heterodímero alfa4-beta7 | |
MX361731B (es) | Método para diagnosticar cáncer y kit de diagnóstico usando medición de actividad de células nk. | |
EP3101407A4 (en) | Protectant for electron microscope observation of hydrated biological sample, kit for electron microscope observation, method for observation, diagnosis, evaluation, or quantification by electron microscope, and sample stage | |
EA201591742A1 (ru) | Способ улучшения диагностики заболеваний с использованием измеряемых аналитов | |
CR20130688A (es) | Método, compuestos y dispositivo para preparar espécimenes citológicos | |
EA201500080A1 (ru) | Способ in vitro диагностирования и мониторинга рака | |
MX380642B (es) | Ceramidas y su uso en el diagnostico de enfermedad cardiovascular (ecv). | |
BR112015019278A2 (pt) | processo de elastografia multi-impulsional | |
CA2839777C (en) | Methods for the prognostic and/or diagnostic of neurodegenerative disease, methods to identify candidate compounds and compounds for treating neurodegenerative disease | |
BR112014009223A2 (pt) | método para o diagnóstico da doença de niemann-pick | |
BR112016024730A2 (pt) | dispositivo, método e conjunto de análise imunocromatográfica | |
EA201990730A1 (ru) | Рнк-биомаркеры для наследственного ангионевротического отека | |
MX2017006075A (es) | Biomarcadores para la progresion de enfermedades en melanoma. | |
MX360479B (es) | Anticuerpos contra microbioma, factores de estres y marcadores de mastocitos como marcadores de diagnostico para ibs. | |
BR112015014232A2 (pt) | lesão renal aguda | |
BR112014031957A2 (pt) | bag3 como soro bioquímico e marcador de tecido | |
MX2019002818A (es) | Metodos para detectar anticuerpos neutralizantes anti-leptina. | |
UY37082A (es) | Anticuerpos monoclonales específicos para el antígeno piii de adenovirus humano (adv), producidos y secretados por hibridomas celulares, útiles para la detección y el diagnóstico de la infección causada por adv | |
WO2015077382A3 (en) | Combined cytology and molecular testing for early detection of esophageal adenocarcinoma | |
WO2017029401A8 (en) | Means and methods for diagnosing cardiac disease in a subject | |
BR112017027707A2 (pt) | método in vitro para o diagnóstico de distúrbios | |
CO6480993A2 (es) | Diagnostico de una parasitosis tal como la leishmaniasis usando un extracto de proteinas ribosomicas (rpe) |